Title:
USE OF TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL TRPV3 IN DEVELOPING DRUG FOR PREVENTION OR TREATMENT OF PSORIASIS
Document Type and Number:
WIPO Patent Application WO/2019/192239
Kind Code:
A1
Abstract:
Disclosed is a pathophysiological effect of the transient receptor potential cation channel, subfamily V, member 3 (TRPV3) on psoriasis, wherein TRPV3 can be used as a target in developing a drug for the treatment of psoriasis.
More Like This:
Inventors:
CAO ZHENGYU (CN)
WANG YUJING (CN)
WANG YUJING (CN)
Application Number:
PCT/CN2019/070763
Publication Date:
October 10, 2019
Filing Date:
January 08, 2019
Export Citation:
Assignee:
UNIV CHINA PHARMA (CN)
International Classes:
A61K45/00; A61P17/06
Domestic Patent References:
WO2008033564A1 | 2008-03-20 | |||
WO2014040178A1 | 2014-03-20 |
Foreign References:
CN101233132A | 2008-07-30 | |||
CN101355946A | 2009-01-28 | |||
US20100137260A1 | 2010-06-03 |
Attorney, Agent or Firm:
NANJING SUGAO PATENT AND TRADEMARK FIRM (ORDINARY PARTNERSHIP) (CN)
Download PDF: